Tamoxifen

An active metabolite of tamoxifen that is formed by the action of CYP2D6 in human liver inhibits MCF-7 and MDA-MB 231 cell proliferation with IC₅₀ values of 27 and 18 &microM, respectively stimulates LC3 lipidation and formation of

An active metabolite of tamoxifen that is formed by the action of CYP2D6 in human liver inhibits MCF-7 and MDA-MB 231 cell proliferation with IC₅₀ values of 27 and 18 &microM, respectively stimulates LC3 lipidation and formation of

An active metabolite of tamoxifen that is formed by the action of CYP2D6 in human liver inhibits MCF-7 and MDA-MB 231 cell proliferation with IC₅₀ values of 27 and 18 &microM, respectively stimulates LC3 lipidation and formation of

An active metabolite of tamoxifen that is formed by the action of CYP2D6 in human liver inhibits MCF-7 and MDA-MB 231 cell proliferation with IC₅₀ values of 27 and 18 &microM, respectively stimulates LC3 lipidation and formation of

Product description：(E/Z)-Endoxifen is an active metabolite of tamoxifen produced by the sequential action of cytochrome P450 (CYP) isoforms, including CYP2D6. It is a strong anti-estrogen, as it has an approximately 100-fold greater affinity for

Application (E/Z)-Endoxifen Hydrochloride Hydrate has been used: as a selective estrogen receptor modulator (SERM) to study the role of miR-27a expression to impregnate a biocompatible polymer in the subcutaneous space adjacent to the TA muscle of

Application (E/Z)-Endoxifen Hydrochloride Hydrate has been used: as a selective estrogen receptor modulator (SERM) to study the role of miR-27a expression to impregnate a biocompatible polymer in the subcutaneous space adjacent to the TA muscle of

An analog of trimethoxy resveratrol inhibits the growth of a variety of human tumor cell lines at concentrations form 0.4 to 2 &microg/ml, which is 5-6 times more potent than resveratrol

Application 4-Hydroxytamoxifen has been used: to induce the recombination of small intestinal organoids. to study its impact on the ability of human peripheral blood mononuclear cells (PMNCs) to form hematopoietic colonies.

Application 4-Hydroxytamoxifen has been used: to induce the recombination of small intestinal organoids. to study its impact on the ability of human peripheral blood mononuclear cells (PMNCs) to form hematopoietic colonies.

4-hydroxytamoxifen (OHT), an active metabolite of tamoxifen, is a selective estrogen receptor modulator, is in wide clinical use for the treatment and prevention of breast cancer.

4-hydroxytamoxifen (OHT), an active metabolite of tamoxifen, is a selective estrogen receptor modulator, is in wide clinical use for the treatment and prevention of breast cancer.